-
-
-
-
-
-
-
BeyondSpring (BYSI) puts more active than calls
-
-
-
-
-
-
-
BeyondSpring (BYSI) puts more active than calls
-
-
-
-
-
-
-
BeyondSpring Announces Second Quarter 2021 Financial Results and Provides a Corporate Update
-
-
-
-
-
-
-
BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China
-
-
-
-
-
-
-
BeyondSpring to Participate in the William Blair Biotech Focus Conference
-
-
-
-
-
-
-
BeyondSpring (BYSI) to Present Three Abstracts from PROTECTIVE-2 Phase 3 Trials of Plinabulin at ASCO
-
-
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

